Pain News and Research

Latest Pain News and Research

Cipher reports net revenue of $1.1 million for 2010 third quarter

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three and nine months ended September 30, 2010.

27 Oct 2010

AZ-TMJ develops effective treatment for migraine headaches

AZ-TMJ is once again leading the way in innovative and effective treatments for severe cases of Temporomandibular Joint Disorders or TMD. AZ-TMJ has developed a variety of highly effective treatments to greatly reduce the frequency and severity of migraine headaches for a large percentage of sufferers. Approximately 16% to 17% of the population suffers from migraine headaches, which often have a debilitating effect on suffers' daily lives.

27 Oct 2010

Marital adjustment associated with better health status for RA patients

Rheumatoid arthritis is a painful and debilitating condition, but a study reported in The Journal of Pain, published by the American Pain Society, shows that being in a strong, non-distressed marriage is associated with experiencing less pain and enjoying better functioning and quality of life.

27 Oct 2010

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type at least when similar doses are given it does appear to reduce gastrointestinal side effects.

27 Oct 2010

Evotec, Apeiron Biologics enter collaboration

Evotec AG today announced that it has entered into a collaboration with Apeiron Biologics AG, to initially identify small molecule modulators of DREAM (Downstream Regulatory Element Antagonistic Modulator), a novel target involved in perception of various pain mechanisms. Further projects will be evaluated to potentially expand this cooperation in due course.

27 Oct 2010

CHORI hosts 2nd annual international Advanced Workshop on Sickle Cell Disease

Children's Hospital & Research Center Oakland is hosting the 2nd annual international Advanced Workshop on Sickle Cell Disease October 28 and 29. This impressive conference will bring together hematologists from Pakistan, Saudi Arabia, Mexico, Venezuela, Brazil, and beyond, and the premier sickle cell experts from the United States for a dialogue on research, comprehensive care, and new treatments and therapies.

27 Oct 2010

Survey shows Americans are unaware about causes of lung cancer

Men and women worry about prostate and breast cancer, yet the number one cancer killer in the United States – lung cancer – isn't on their radar. According to a survey released today by the National Lung Cancer Partnership, Americans know little about lung cancer's causes, symptoms and the number of lives it takes compared to other cancers.

27 Oct 2010

Pain could predict survival of liver cancer patients

Understanding the role of pain hepatocellular carcinoma (HCC) or liver cancer is critical since pain has adverse effects on quality of life and could be a predictor of survival, according to research reported in The Journal of Pain, published by the American Pain Society, www.ampainsoc.org.

27 Oct 2010

New technologies streamline health IT system; Electronic medical records raise privacy issues

The Associated Press: Although many healthcare providers are making the jump to computerized medical records, an "e-chart stored in one doctor's computer too often can't be read by another's across town." Surescripts, "the country's largest network for paperless prescribing," is expanding "so that doctors around the country can choose to share medical reports, X-rays and other health data over its network much as they send e-prescriptions to drugstores today, regardless of what competing brand of computerized health records they use."

27 Oct 2010

PinPointe FootLaser receives FDA clearance for treatment of nail fungus

The podiatry practice of Mark E. Spier, DPM, announced today that the PinPointe™ FootLaser™ has received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of nail fungus (onychomycosis). Dr. Spier is the first certified provider of the treatment in the Baltimore area.

26 Oct 2010

Purdue and Mundipharma assume worldwide development for Infinity's fatty acid amide hydrolase program

Infinity Pharmaceuticals, Inc. today announced that Purdue Pharmaceutical Products L.P. and its independent associated company, Mundipharma International Corporation Ltd., have exercised their right to assume worldwide development and commercialization activities for Infinity's fatty acid amide hydrolase, or FAAH, program. The decision reflects progress made in the development of Infinity's oral FAAH inhibitor, IPI-940.

26 Oct 2010

Admissions for medication, drug-related conditions increase by 117% among Americans aged 45 and older

The number of hospital admissions among Americans ages 45 and older for medication and drug-related conditions doubled between 1997 and 2008, according to a new report released today by HHS' Agency for Healthcare Research and Quality. Medication and drug-related conditions include effects of both prescription and over-the-counter medications as well as illicit drugs.

26 Oct 2010

Salk discovers potential new target for MS

Scientists are closer to solving one of the many mysteries of multiple sclerosis and other demyelinating diseases, thanks to a recent study conducted at the Salk Institute for Biological Studies. The research revealed a previously unknown connection between two ion channels, which, when misaligned, can cause the many bizarre symptoms that characterize the condition.

26 Oct 2010

Sanofi Pasteur presents Fluzone quadrivalent Phase II trial data for influenza at IDSA Annual Meeting

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group announced today the results of a clinical trial of its investigational Fluzone Quadrivalent (Influenza Virus Vaccine) compared to the currently licensed Fluzone (Influenza Virus Vaccine). Data from the Phase II trial assessing the immunogenicity and safety of the investigational quadrivalent vaccine were presented at the 48th Annual Meeting of the Infectious Diseases Society of America in Vancouver, British Columbia.

26 Oct 2010

Take McAlester Back campaign for drug-free life

The word to describe yesterday's Take McAlester Back events is inspiring. The group kicked of their official campaign Saturday morning on Choctaw Avenue. Take McAlester Back is a grassroots movement to get drugs out and arts in, all throughout Southeastern Oklahoma.

26 Oct 2010

Barriers for female heart patients entering cardiac rehab

Cardiac rehabilitation is considered the pillar of preventing a second cardiac event yet those who stand to benefit the most - women and the elderly − are often missing out, Dr. Billie Jean Martin told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular Congress 2010 this week.

25 Oct 2010

$Precautions needed against cold-related frostbite, ankle sprains and fractures$

Precautions needed against cold-related frostbite, ankle sprains and fractures

With cold weather on the horizon, podiatrists at Temple University's School of Podiatric Medicine warn that people of all ages need to take precautions to protect their feet from cold-related injuries like frostbite, ankle sprains and fractures.

25 Oct 2010

Anxiety sensitivity levels may help in choosing medical treatment for AF patients

Levels of anxiety sensitivity may be important in choosing medical treatment for patients with heart failure and atrial fibrillation (AF), Montreal Heart Institute researchers today told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

Kryptonite adhesive can improve quality of heart patients recovering from open-chest surgery

New research shows that a surgical procedure using a cutting-edge super glue pioneered a year ago by Calgary researchers can improve the recovery of heart patients recovering from open-chest surgery, Dr. Paul Fedak today told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

Pain News and Research

Latest Pain News and Research

Cipher reports net revenue of $1.1 million for 2010 third quarter

AZ-TMJ develops effective treatment for migraine headaches

Marital adjustment associated with better health status for RA patients

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

Evotec, Apeiron Biologics enter collaboration

CHORI hosts 2nd annual international Advanced Workshop on Sickle Cell Disease

Survey shows Americans are unaware about causes of lung cancer

Pain could predict survival of liver cancer patients

New technologies streamline health IT system; Electronic medical records raise privacy issues

PinPointe FootLaser receives FDA clearance for treatment of nail fungus

Purdue and Mundipharma assume worldwide development for Infinity's fatty acid amide hydrolase program

Admissions for medication, drug-related conditions increase by 117% among Americans aged 45 and older

Salk discovers potential new target for MS

Sanofi Pasteur presents Fluzone quadrivalent Phase II trial data for influenza at IDSA Annual Meeting

Take McAlester Back campaign for drug-free life

Barriers for female heart patients entering cardiac rehab

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Precautions needed against cold-related frostbite, ankle sprains and fractures

Anxiety sensitivity levels may help in choosing medical treatment for AF patients

Kryptonite adhesive can improve quality of heart patients recovering from open-chest surgery

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Pain News and Research

Latest Pain News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in